A call informs Sarah Nealle her six-year-old daughter was in a school bus accident.
Her journey includes: Doctors. An epidural hematoma. Respirators. Apnea tests. Nationwide publicity. Political, moral, ethical, legal, social battles regarding organ transplantation. A family with disagreements.
The lonely decision: how to let her daughter die with dignity. Find out more at http://garybshelly.com/ Literary
Results from a large retrospective data analysis published in the American Journal of Transplantation (AJT) today, showed that liver transplantation patients who were treated early with Advagraf experienced a significantly increased graft survival benefit of 8% at 3 years post-transplant compared with patients treated with the current standard of care, tacrolimus immediate release (twice daily).
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7451251-advagraf-prolonged-release-tacrolimus/
‘Tackling hepatitis C: Moving towards an integrated policy approach’, a report published by The Economist Intelligence Unit (EIU) today reveals that many countries around the world have been slow to respond with national policies on hepatitis C despite recent government pledges to fight the disease. The hepatitis C virus remains the leading cause of liver cancer, liver disease and liver transplantation placing a huge burden on patients' lives and healthcare systems.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/71400562-janssen-new-reports-hepatitis-c
A new Economist Intelligence Unit (EIU) report titled The Silent Pandemic: Tackling Hepatitis C with Policy Innovation, made possible as a result of an educational grant from Janssen Pharmaceutica NV and published today, highlights the urgent need for countries around the world to develop strategies to tackle head-on the growing social and economic issues associated with Hepatitis C (HCV).
While the total number of infected individuals is unknown due to a lack of available data, the World Health Organization (WHO) estimates that approximately 150 million people globally are currently living with the blood-borne infectious disease, HCV. Of these, up to two thirds will develop chronic liver disease and one in five will develop cirrhosis. HCV is also the leading cause of liver transplantation worldwide and in the US the disease now accounts for more deaths than HIV.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58671-janssen-silent-pandemic-hepatitis-c
